Benefits of ERBB signaling, for example, have been applied in recent therapies for heart failure patients, where a phase I clinical trial is testing an NRG isoform associated with the ERBB signaling pathway as a therapy for heart failure [74]. This evidence concerns the gene EGFR and heart failure.